Humoral immunity to aerosolized staphylococcal enterotoxin B (SEB), a superantigen, in monkeys vaccinated with SEB toxoid-containing microspheres.

Infection and Immunity
J TsengD L Ruble

Abstract

Staphylococcal enterotoxin B (SEB) toxoid-containing microspheres were tested for efficacy in rhesus monkeys as a vaccine candidate for respiratory SEB toxicosis and toxic shock. Forty monkeys were randomly separated into 10 groups of four monkeys each: 9 groups were vaccinated with the microspheres via combinations of mucosal and nonmucosal routes, and 1 group served as nonvaccinated controls. Both vaccinated and nonvaccinated monkeys were then challenged with a high lethal dose of SEB aerosol. Monkeys primed with an intramuscular dose of the microspheres followed by an intratracheal booster all survived the SEB challenge. Overall, monkeys with an intratracheal booster generally had the highest antibody levels, which is consistent with their high survival rate and lower rate of illness. Protective immunity was correlated with antibody levels in both the circulation and the respiratory tract. The protection was not due to the depletion or anergy of SEB-reactive T cells, since SEB-induced proliferation in cultures of circulating lymphocytes was not significantly reduced after the microsphere vaccination. It is evident that the nonsurvivors did not die of systemic anaphylaxis or hypersensitivity because the monkeys did not die im...Continue Reading

References

Feb 1, 1977·The Australian Journal of Experimental Biology and Medical Science·D Rowley
Jul 1, 1992·Infection and Immunity·J KomisarJ Tseng
Sep 1, 1991·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·H M JohnsonC H Pontzer
Oct 1, 1990·The Journal of Experimental Medicine·Y Kawabe, A Ochi
Oct 1, 1990·The Journal of Experimental Medicine·B L RellahanL A Matis
Feb 1, 1990·The Journal of Experimental Medicine·P MarrackJ Kappler
Nov 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·Y W ChoiJ Kappler
Dec 1, 1989·The Journal of Allergy and Clinical Immunology·G AlberD K Hammer
Jan 1, 1987·International Archives of Allergy and Applied Immunology·P H ScheuberD K Hammer
Mar 1, 1988·Annals of Emergency Medicine·S W Wright, A T Trott
Jun 1, 1985·European Journal of Immunology·P SiderasE Severinson
Aug 1, 1972·Toxicon : Official Journal of the International Society on Toxinology·W R Beisel
Jun 1, 1965·Biochemistry·E J SchantzM S Bergdoll
Apr 1, 1966·The Journal of Infectious Diseases·M S Bergdoll

❮ Previous
Next ❯

Citations

Mar 21, 1998·The Journal of Pharmacy and Pharmacology·D T O'Hagan
Jun 8, 1999·Annual Review of Immunology·H LiR A Mariuzza
Jul 6, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·T J CieslakE M Eitzen
Apr 16, 2002·Infection and Immunity·Ross D LeClaireSina Bavari
Nov 2, 2006·Expert Opinion on Drug Delivery·Ed C Lavelle, D T O'Hagan
Aug 1, 2010·Toxins·Irina V PinchukVictor E Reyes
Nov 5, 1999·Nature Biotechnology·M Singh, D O'Hagan
Nov 26, 2010·Expert Review of Vaccines·Antu K Dey, Indresh K Srivastava
Apr 3, 2016·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Yuchen Fan, James J Moon
Mar 16, 2002·Infection and Immunity·Jeffrey W ShuppCarol H Pontzer
Nov 3, 2010·Journal of Drug Targeting·Barbara C Baudner, Derek T O'Hagan
Jun 6, 2000·Advanced Drug Delivery Reviews·R LangerJ Hanes
Dec 1, 2013·Microbiology Spectrum·Bettina C Fries, Avanish K Varshney
Dec 1, 1996·Journal of Pharmaceutical Sciences·Z Zhao, K W Leong
Jun 7, 2005·Advanced Drug Delivery Reviews·Wyatt ByrdFrederick J Cassels
Jun 7, 2005·Advanced Drug Delivery Reviews·Nicholas J Mantis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Anaphylaxis

Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death.